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Abstract  29 
 30 
Yawning is a significant behavioural response and, together with cortisol, is 31 
potentially a new diagnostic marker of neurological diseases. Evidence of an 32 
association between yawning and cortisol was found which supports the Thompson 33 
Cortisol Hypothesis and thermoregulation hypotheses, indication that brain cooling 34 
occurs when yawning. 117 volunteers aged 18-69 years were randomly allocated to 35 
experimentally controlled conditions to provoke yawning. Thirty-three had been 36 
diagnosed with multiple sclerosis. Saliva cortisol samples were collected before and 37 
after yawning or after stimuli presentation in the absence of yawning. Hospital 38 
Anxiety and Depression Scale, General Health Questionnaire, demographic and 39 
health details were collected. Comparisons were made of yawners and non-yawners, 40 
healthy volunteers and MS participants. Exclusion criteria: chronic fatigue, diabetes, 41 
fibromyalgia, heart condition, high blood pressure, hormone replacement therapy, 42 
stroke. Yawners had significant differences between saliva cortisol sample 1 and 2 43 
among healthy participants (p<.007) and MS participants (p<.003). There was 44 
significant difference between the healthy versus MS non-yawners (P<.042) but not 45 
between yawners (p<.862). These results support the Thompson Cortisol 46 
Hypothesis suggesting that cortisol levels are elevated during yawning. Furthermore, 47 
this evidence suggests cortisol levels in the MS participants (non-yawners) are 48 
significantly different to those of healthy participants. Changes in cortisol levels 49 
may be similar in healthy and MS participants but when associated with 50 
observations of excessive yawning may become a new diagnostic tool in the early 51 
diagnosis of neurological symptoms.  52 
 53 
 54 
Introduction 55 
 56 
The first evidence-based report of cortisol level rises in multiple sclerosis (MS) 57 
together with observed yawning is presented as a potential new diagnostic indicator 58 
of signs associated with the onset of MS.  59 
MS is a chronic debilitating condition that is progressive and affects the fatty 60 
tissue sheath surrounding nerves. Incomplete innervation due to loss of the myelin 61 
sheath is considered to be responsible for uncoordinated movements (1). Brain 62 
temperature fluctuations are seen in people with MS together with symptoms of 63 
fatigue and especially when carrying out mentally or physically demanding tasks. 64 
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These are also associated with excessive yawning (2-3). Yet the cause of fatigue in 65 
MS is not fully understood. 66 
Attempts to clarify brain recruitment during fatigue in MS has revealed 67 
involvement of the dorsolateral prefrontal cortex, , inferior parietal cortex, anterior 68 
cingulate cortex and the thalamus (4).  69 
Fatigue in MS has been investigated using variations in inducing fatigue 70 
together with MRI scans to determine functional areas of brain activation. For 71 
example, Thompson et al. (5) discovered that cortisol levels were found to be higher 72 
during mental versus motor (physical) tasks. Recruitment of brainstem and 73 
hypothalamus regions, important in cortisol activity, was affected differently (Fig 1).  74 
Fig 1. Brain scans of hypothalamus and brainstem activity averaged across 75 
participants (5) 76 
 77 
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At low cortisol levels, mental task participants had less activity in the 80 
hypothalamus than their physical task counterparts (Fig 2). When cortisol levels 81 
were higher, wider spread recruitment of both the hypothalamus and brainstem was 82 
observed in the mental task participants, and for the physical task participants, the 83 
spread was at comparative low levels of cortisol. 84 
Fig 2. Brain scans of hypothalamus activity in “Mental” versus and “Physical” 85 
task participant at lowest level of cortisol (5) 86 
 87 
                           Mental                                   Physical 88 
The authors concluded that cortisol is implicated in these brain regions and 89 
that brain region recruitment is likely to be dependent upon factors such as 90 
perception of stress in the task. It is likely that the mental tasks were perceived more 91 
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stressful than the physical tasks and therefore required higher cortisol levels to 92 
promote wider spread brain region activity.  93 
The hormone cortisol has been associated with yawning and fatigue and 94 
described in the Thompson Cortisol Hypothesis (6). Threshold level rises of cortisol 95 
appear to trigger the yawn which is proposed to be part of a complex mechanism for 96 
lowering brain temperature (7). Brain temperature rises dramatically in people with 97 
MS (8) and it has been proposed that cortisol is able to regulate brain temperature 98 
because of its role within the hypothalamus-pituitary-adrenal (HPA-axis) (9), even 99 
in the foetus and in young babies (10). 100 
Secretion of cortisol is controlled by three inter-communicating regions of the 101 
brain: hypothalamus, pituitary and adrenal glands. During low levels of cortisol in 102 
the blood, the hypothalamus releases corticotrophin-releasing hormone causing the 103 
pituitary gland to secrete adrenocorticotropic hormone into the bloodstream. High 104 
levels of adrenocorticotropic hormone are detected in the adrenal glands which 105 
stimulate the secretion of cortisol, causing blood levels of cortisol to rise. As the 106 
cortisol levels rise, they start to block the release of corticotrophin-releasing 107 
hormone from the hypothalamus and adrenocorticotropic hormone from the 108 
pituitary (7). As a result, the adrenocorticotropic hormone levels start to fall 109 
resulting in a fall in cortisol levels. This mechanism is known as a negative 110 
feedback loop. 111 
Cortisol has been noted during exposure to stressful events and may even be 112 
modulated by contagious yawning (11). Yawning has also been observed to reduce 113 
facial temperature in rats (12) but substantive evidence of brain cooling in humans 114 
has been elusive to date. 115 
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Thompson (13-14) presented the Thompson Cortisol Hypothesis which is the 116 
first evidence-based report linking cortisol with yawning in healthy participants and 117 
demonstrates that cortisol rises when we yawn. Other researchers have postulated 118 
that yawning may promote increased clearing of central nervous system-derived 119 
fluid into the central venous structures (15-16). 120 
Produced by the zona fasciculate of the adrenal cortex within the adrenal 121 
gland (17), it is suggested that the rise in cortisol level triggers the yawning response 122 
in healthy people. When we become fatigued either mentally or physically, and in 123 
particular in MS, yawning becomes important for regulating cortisol. We believe 124 
that cortisol also affects the hypothalamus temperature regulation within the HPA-125 
axis and may signal brain cooling particularly when elevation in brain temperature 126 
is common such as in MS. 127 
 In addition to the hypothalamus, evidence of the effects of cortisol has been 128 
found in the brainstem and motor cortex (18). Hasan et al. (19) found sophisticated 129 
motor receptors in mice. The efficiency of cortisol-specific receptors and the 130 
communication between sensory and primary motor neurons is enhanced during 131 
motor learning.  132 
It is postulated that the link between the established sites within the HPA-axis 133 
and those of the motor cortex and brainstem may be less intimately linked by neural 134 
networks but instead by hormone system. This would help in our understanding of 135 
why brainstem lesion stroke patients may raise their affected arm during yawning 136 
where the yawning response is possibly triggered by threshold levels of cortisol. 137 
Cortisol-specific receptors on the motor end plates would give rise to muscle 138 
movements in the arm. 139 
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In stroke patients, cortisol levels may be inadequately detected and due to 140 
incomplete innervation, the brainstem may fail to act on changes in cortisol levels to 141 
prevent arm movement resulting in the observed parakinesia brachialis oscitans 142 
seen in brainstem ischaemic patients (20-21). Whilst it is accepted that hormones 143 
work within a system that comprises other hormones and complex neural circuitry, 144 
it is often through direct observation that pathways can be understood. It is hoped 145 
that such observation of people with MS (and yawning and cortisol) might provide 146 
us with an increased understanding of why brain temperature fluctuates with fatigue. 147 
This might have greater implications for people with a wide range of neurological 148 
disorders and cortisol-insufficiency syndromes such as Cushing’s disease (22). It 149 
may also be a potential diagnostic tool for detecting the signs of MS in the future. 150 
 151 
Materials and methods 152 
 153 
Participants 154 
 155 
One-hundred-and-seventeen volunteers were recruited to the study. Eighty-156 
four healthy volunteers (30 male, 54 female) aged between 18-69 years recruited 157 
from students and the research volunteer pool at Bournemouth University using the 158 
computerised recruitment system (SONA), and Facebook. Two of these participants 159 
were subsequently excluded from data analyses due to the analytical laboratory 160 
receiving two sets of dry saliva samples.  161 
A further 33 volunteers (12 male, 21 female) who had a diagnosis of multiple 162 
sclerosis were recruited from attendees of the Multiple Sclerosis Society 163 
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Bournemouth Branch and were aged between 34-70 years). All participants were 164 
properly consented according to code of conduct and research guidelines. Exclusion 165 
criteria was: chronic fatigue, congestive heart disorder, diabetes, fibromyalgia, heart 166 
condition, high blood pressure, history of stress, psychiatric disorder, hormone 167 
replacement therapy, renal problems, respiratory disorder, stroke, and multiple 168 
sclerosis (except for the multiple sclerosis participants). 169 
 170 
Stimuli and procedure 171 
 172 
As described in detail previously (23), all participants were exposed to three 173 
conditions intended to provoke a yawning response – photos of people yawning; 174 
short video of person yawning; and reading to self a ‘boring’ lengthy text about 175 
yawning. Comparisons were made with those exposed to the same conditions but 176 
who did not yawn.  177 
Saliva samples were collected before and again after the yawning response. If 178 
there was no yawning response, then a second saliva sample was taken after the last 179 
stimulus was presented. Cortisol levels are easily detected in saliva and are a less 180 
intrusive collection method than intravenous cortisol collection. Presence of cortisol 181 
in saliva is highly correlated with blood assay (24-26) and it is also much cheaper to 182 
analyse in the laboratory.  183 
The Hospital Anxiety and Depression Scale (HADS) (27), General Health 184 
Questionnaire (GHQ28) (28-29) and demographic and health details were collected 185 
from all participants.  186 
Between- and within-participants comparisons were made using t-tests in the 187 
SPSS package version 23. This enabled a comparison to be made between rest 188 
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status and yawning episodes (where yawning occurred); yawning and non-yawning 189 
participants; and healthy and multiple sclerosis participants. 190 
 191 
Ethics 192 
 193 
Bournemouth University Research & Ethics approval granted: 194 
DEC/PS03.10.11; 05.10.11; 01.03.12; 18.10.12; DEC/JC28.01.13; FST/KA06.09.13; 195 
FST/SB26.09.16; Multiple Sclerosis Society: MSSBB/RS11.01.17. Protective 196 
measures were put in place for collection and analysis of saliva samples; for 197 
example, disposable gloves were worn during collection and analysis. All data was 198 
coded for anonymity, confidentiality and privacy held in a secure location. The right 199 
of participants to withdraw from the study at any time without consequences was 200 
upheld and all saliva cortisol samples were destroyed following analysis. 201 
 202 
Results 203 
 204 
The mean age of the healthy participants was 28 years compared with 57 205 
years for the MS participants. There were no significant differences between groups 206 
in terms of HADS anxiety and depression scores and GHQ28 scores. Normative 207 
data for saliva cortisol is known, and lies within the following ranges: (i) Morning 208 
collection is 3.7 – 9.5 nanograms (one billionth of a gram or 10-9) per millilitre of 209 
saliva; (ii) Noon collection is 1.2 – 3.0 nanograms per millilitre; (iii) Evening 210 
collection is 0.6 – 1.9 nanograms per millilitre.  211 
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For the healthy participants, there was no significant difference (p<.106) 212 
between cortisol sample 1 and 2 for the non-yawners. For the participants with MS, 213 
there was also no significant difference (p<.183) for the non-yawners (Tables 1 and 214 
2).  215 
Table 1. (Descriptive data) Healthy Group Non-Yawners: Cortisol Sample 1 216 
                                       vs Cortisol Sample 2  217 
                                        
Paired Samples Statistics 
  Mean N 
Std. 
Deviation Std. Error Mean 
Control  Pair 1 Saliva sample 1 2.1814 43 1.67264 .25508 
Saliva sample 2 2.4930 43 2.08423 .31784 
MS  Pair 1 Saliva sample 1 10.3500 18 23.84287 5.61982 
Saliva sample 2 7.0000 18 13.62580 3.21163 
 
 
Table 2. (Test data) Healthy Group Non-Yawners: Cortisol Sample 1 vs 218 
                           Cortisol Sample 2  219 
 220 
Paired Samples Test 
  
Paired Differences 
t df 
Sig. 
(2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Control  Pair 1 Saliva 
sample 1 - 
Saliva 
sample 2 
-.31163 1.23755 .18872 -.69249 .06923 -1.651 42 .106 
MS  Pair 1 Saliva 
sample 1 - 
Saliva 
sample 2 
3.35000 10.25006 2.41596 -1.74724 8.44724 1.387 17 .183 
 221 
However, significant difference (p<.007) was found between cortisol sample 1 222 
and 2 in the healthy participants; and in the MS participants, there was a greater 223 
significant difference of p<.003 (Tables 3 and 4).  224 
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Table 3. (Descriptive data) MS Yawners: Cortisol Sample 1 vs Cortisol Sample 225 
2 226 
 227 
 228 
 229 
 230 
 231 
 232 
 233 
 234 
 235 
 236 
 237 
 238 
Table 4. (Test data) MS Yawners: Cortisol Sample 1 vs Cortisol Sample 2 239 
                          240 
 241 
Comparison between healthy participants and MS participants revealed 242 
significant difference (p<.042) between their second cortisol sample (Table 5) 243 
suggesting that the level of cortisol in those with MS is significantly different. 244 
However, in the yawners, there was no significant difference (p<.862) between the 245 
two groups (Table 6). This may indicate that changes in cortisol levels are similar in 246 
both groups but actual levels of cortisol are significantly different and therefore 247 
worthy of further investigation. 248 
Table 5. Cortisol Sample 2 Non-Yawners: Healthy Group vs MS 249 
 250 
Independent Samples Test 
Paired Samples Statistics 
  Mean N Std. Deviation 
Std. Error 
Mean 
Control Pair 1 Saliva sample 1 2.6341 41 1.99231 .31115 
Saliva sample 2 3.1268 41 2.26550 .35381 
MS  Pair 1 Saliva sample 1 2.5867 15 1.11859 .28882 
Saliva sample 2 3.1000 15 1.03026 .26601 
 
Paired Samples Test 
  
Paired Differences 
t df 
Sig. 
(2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Control  Pair 1 Saliva sample 1 - 
Saliva sample 2 
-.49268 1.10914 .17322 -.84277 -.14259 -2.844 40 .007 
MS Pair 1 Saliva sample 1 - 
Saliva sample 2 
-.51333 .56299 .14536 -.82510 -.20156 -3.531 14 .003 
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Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
F Sig. T df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Saliva_2 Equal 
variances 
assumed 
7.273 .009 -2.083 58 .042 -4.44762 2.13538 -8.72205 -.17319 
Equal 
variances 
not 
assumed 
  -1.378 17.338 .186 -4.44762 3.22751 -11.24697 2.35174 
 251 
Table 6. Cortisol Sample 2 Yawners: Healthy Group vs MS 252 
 253 
Independent Samples Test 
 
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
F Sig. T df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Saliva_2 Equal 
variances 
assumed 
4.979 .030 .174 53 .862 .10500 .60287 -1.10420 1.31420 
Equal 
variances 
not 
assumed 
  .237 50.553 .813 .10500 .44265 -.78385 .99385 
 254 
Discussion 255 
 256 
There are several interesting findings of this study. Of those participants who 257 
did not yawn, the cortisol samples at rest and then at the end of stimuli presentations 258 
was not significantly different within each group of participants. This is perhaps not 259 
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surprising since it is known that cortisol levels rise during episodes of stress, 260 
whether perceived to be mentally fatiguing or if they are physically demanding. It 261 
may be that for those who did not yawn, the tasks were not demanding in mental or 262 
physical terms. 263 
It is interesting that those participants with MS who did not yawn also had no 264 
significant difference in their cortisol levels which tends to suggest that, in the 265 
absence of yawning, cortisol levels in these participants did not significantly change 266 
by the end of the testing session. 267 
Perhaps of more scientific interest is the finding that participants who yawned 268 
had elevated cortisol levels. Previous studies by the research team have found that 269 
in healthy participants who yawn their cortisol levels rise significantly (10,23). 270 
People who have MS often become fatigued and yawning are often observed as a 271 
common symptom of MS (8). Therefore, it is of note that in those MS participants 272 
who did yawn during the stimuli presentations, their cortisol levels significantly 273 
raised in levels greater than their resting levels. It is also of note that not all of the 274 
participants yawned; this may be because their symptoms of MS were not identical 275 
to those who did yawn. Alternatively, it may be due to threshold levels of cortisol 276 
not being reached, as compared with healthy participants who did not yawn. 277 
It is proposed that people with threshold levels of cortisol yawn, whether they 278 
have MS or not; however, changes in cortisol levels after yawning were not 279 
significantly different between the healthy and MS participants although there was a 280 
significant difference between the groups in their second saliva sample for the non-281 
yawners. This is interesting because significant difference in levels between healthy 282 
participants and those with MS might suggest that cortisol levels are important in 283 
MS; and when associated with excessive yawning, these levels may signal MS 284 
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symptoms. It will be interesting to see if the effects of these cortisol levels are 285 
directly correlated to lowering brain temperature since yawning seems to lower 286 
temperature.  287 
These findings tend to support the Thompson Cortisol Hypothesis (1,6) that 288 
proposes yawning occurs when threshold levels of cortisol are reached in order to 289 
reduce brain temperature. This is shown in both the healthy and MS participants. 290 
Communication with the motor cortex via cortisol-specific receptors may also 291 
explain how involuntary movement of the arm in brainstem ischaemic patients can 292 
occur partly due to incomplete innervation and irregulation of cortisol within the 293 
HPA-axis which has been extensively discussed elsewhere (1,20,21,30). 294 
The picture in neurological and biological diseases is complex because they 295 
present with a range of symptoms and severity. However, cortisol features in many 296 
disorders as well as the body’s natural stress hormone. Hence it is suggested that it 297 
may provide an important key to our understanding of the way many neurological 298 
disorders are linked. It may also provide scientists and practitioners in the near 299 
future with a potential identifier or even diagnostic indicator of underlying and 300 
untoward neurological disease systems including MS. 301 
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